Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON53991Phase 4Recruiting
Phase 4, open-label trial in chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTED) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary composite endpoint. Started Mar 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON53991.